HER2 Testing in Breast Cancer: ASCO-CAP Guideline Update

HER2 Testing in Breast Cancer: ASCO-CAP Guide...

Up next

Management of Cancer During Pregnancy Guideline

Dr. Alison Loren and Dr. Ann Partridge share the latest guideline from ASCO on the management of cancer during pregnancy. They highlight the importance of this multidisciplinary, evidence-based guideline and overarching principles for the management of cancer during pregnancy. Dr ...  Show more

Management of Antineoplastic Extravasation: ONS-ASCO Guideline

Dr. Tanya Thomas and Dr. Aparna Jotwani join the podcast to discuss the new Oncology Nursing Society and American Society of Clinical Oncology evidence-based guideline on the management of antineoplastic extravasation. They discuss recommendations from the expert panel on: manage ...  Show more

Recommended Episodes

ASCO23: PALMIRA, LEONARDA-1, and Other Advances in Breast Cancer
ASCO Daily News

<div class="OutlineElement Ltr SCXW250592669 BCX0">

Dr. Allison Zibelli and Dr. Megan Kruse highlight the PALMIRA and LEONARDA-1 trials, a new standard of care in the treatment of hand-foot syndrome for patients receiving capecitabine, and ...

  Show more

ASCO24: The Era of the ADCs in NSCLC
ASCO Daily News

Drs. Vamsi Velcheti and Nathan Pennell discuss key lung cancer abstracts from the 2024 ASCO Annual Meeting, including data from LUMINOSITY and ADAURA, novel therapies in KRASG12C-mutant advanced NSCLC, and the need for effective adjuvant therapies for patients with rare mutati ...

  Show more

THOR, CONTACT-03, and Other Advances in GU Cancers at ASCO23
ASCO Daily News

<div class="OutlineElement Ltr SCXW112417831 BCX0">

<span style= "font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, Cantarell, 'Open Sans', 'Helvetica Neue', sans-serif;"> Drs. Rana McKay and Jonathan Rosen ...

  Show more

ADCs in Breast Cancer: Sequencing, Resistance, and Managing Toxicity
ASCO Daily News

<span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">Drs. Hope Rugo and Sara Tolaney discuss the promise of antibody-drug conjugates (ADCs) in the treatment of breast cancer, highlighting key trials that shed light on matching the right ADC to the right p ...

  Show more